ciglitazone has been researched along with Acute Confusional Senile Dementia in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, JC | 1 |
| Friel, SL | 1 |
| Roman, S | 1 |
| Perren, M | 1 |
| Harper, A | 1 |
| Davis, JB | 1 |
| Richardson, JC | 1 |
| Virley, D | 1 |
| Medhurst, AD | 1 |
1 other study available for ciglitazone and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Autoradiographical imaging of PPARgamma agonist effects on PBR/TSPO binding in TASTPM mice.
Topics: Acetamides; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid | 2009 |